Scottsdale, Arizona (PRWEB) February 26, 2012
QualityStocks would like to highlight SANUWAVE Health, Inc., a publicly traded regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal, and vascular structures. SANUWAVE’s portfolio of products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration.
In the company’s news Friday,
SANUWAVE Health announced it has signed a two-year exclusive distribution agreement with CAN-med Healthcare of Canada, in which CAN-med will distribute SANUWAVE’s Pulsed Acoustic Cellular Expression (PACE®) technology for acute and chronic wound healing.
CAN-med distributes a wide range of medical offerings, including wound care and trauma products complementary of SANUWAVE’s dermaPACE.
“CAN-med Healthcare is a welcome addition to our growing distribution network for PACE technology, and they have the distinct honor of being the first PACE distributor in North America,” Christopher M. Cashman, president and CEO of SANUWAVE, stated in the press release. “dermaPACE is approved in Canada to treat a wide range of acute and chronic wounds. CAN-med Healthcare’s initial focus will be on the treatment of diabetic foot ulcers, leveraging positive data from our recently completed pivotal clinical trial investigating dermaPACE to treat these debilitating and costly ulcers.
“This collaboration is exciting news for both organizations, and we are equally committed to the hard work ahead of us to reach our ultimate goal of establishing dermaPACE as a first-line wound healing technology with established reimbursement throughout Canada.”
Stephen McDonald, CAN-med’s vice president and general manager, noted the beneficial impact the agreement has on his company and the Canadian healthcare market.
“dermaPACE technology is a great fit for us, as it builds upon our legacy of bringing new, leading edge products to the Canadian market. As a company, we’re always looking for exclusive partnerships that involve innovative, clinically validated and differentiated technology that can improve patient outcomes and overall delivery of care. We believe we’ve met these objectives with SANUWAVE,” McDonald stated.
Jim Ritcey, director of sales and marketing for CAN-med, echoed McDonald’s sentiment.
“It is the mandate of every health department in Canada to improve care to all Canadians, while staying within the confines of increasingly tighter budgets,” Ritcey stated. “We believe that dermaPACE, with its proven safety and efficacy, combined with its potential to reduce costs associated with chronic wound care, could truly be a ‘game changer’ in the battle against chronic wounds.”
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit http://www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.